{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:35:22Z","timestamp":1785803722930,"version":"3.56.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30DK065988"],"award-info":[{"award-number":["P30DK065988"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","award":["1\/2020"],"award-info":[{"award-number":["1\/2020"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","award":["7\/2013"],"award-info":[{"award-number":["7\/2013"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","award":["FFC#9\/2020"],"award-info":[{"award-number":["FFC#9\/2020"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["3M210333"],"award-info":[{"award-number":["3M210333"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006282","name":"King Baudouin Foundation","doi-asserted-by":"publisher","award":["2020-J1810150-217924"],"award-info":[{"award-number":["2020-J1810150-217924"]}],"id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF 001713G220"],"award-info":[{"award-number":["CFF 001713G220"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GENTZS18P0"],"award-info":[{"award-number":["GENTZS18P0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GENTZS19I0"],"award-info":[{"award-number":["GENTZS19I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BOUCHE19R0"],"award-info":[{"award-number":["BOUCHE19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:03:04Z","timestamp":1671206584000},"page":"S32-S38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Patient-derived cell models for personalized medicine approaches in cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Anabela S.","family":"Ramalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-2933","authenticated-orcid":false,"given":"Felice","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-0321","authenticated-orcid":false,"given":"Martina","family":"Gentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2022.11.007_bib0001","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jcf.2022.11.007_bib0002","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0003","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion channel modulators in cystic fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2022.11.007_bib0004","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcf.2022.11.007_bib0005","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0006","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2022.11.007_bib0007","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0008","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acsptsci.9b00060","article-title":"Emerging cystic fibrosis transmembrane conductance regulator modulators as new drugs for cystic fibrosis: a portrait of in vitro pharmacology and clinical translation","volume":"3","author":"Ghelani","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jcf.2022.11.007_bib0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2019.07.037","article-title":"An overview on chemical structures as DeltaF508-CFTR correctors","volume":"180","author":"Spano","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jcf.2022.11.007_bib0011","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/17460441.2021.1912732","article-title":"Discovery of CFTR modulators for the treatment of cystic fibrosis","volume":"16","author":"Lopes-Pacheco","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.jcf.2022.11.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112631","article-title":"Current development of CFTR potentiators in the last decade","volume":"204","author":"Spano","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jcf.2022.11.007_bib0013","unstructured":"Cystic Fibrosis Foundation Drug Development Pipeline, https:\/\/www.cff.org\/Trials\/Pipeline. 2022."},{"key":"10.1016\/j.jcf.2022.11.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.04.019","article-title":"Caution advised in the use of CFTR modulator treatment for individuals harboring specific CFTR variants","author":"Raraigh","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009100","article-title":"Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies","volume":"16","author":"Joynt","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jcf.2022.11.007_bib0016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.14639\/0392-100X-1328","article-title":"An \"ex vivo model\" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis","volume":"37","author":"Di Lullo","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.jcf.2022.11.007_bib0017","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99385","article-title":"Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies","volume":"3","author":"Brewington","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcf.2022.11.007_bib0018","first-page":"9","article-title":"Ionocytes and CFTR chloride channel expression in normal and cystic fibrosis nasal and bronchial epithelial cells","author":"Scudieri","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jcf.2022.11.007_bib0019","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/humu.23741","article-title":"Two CFTR mutations within codon 970 differently impact on the chloride channel functionality","volume":"40","author":"Amato","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jcf.2022.11.007_bib0020","first-page":"56","article-title":"Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations","author":"McCravy","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.007_bib0021","doi-asserted-by":"crossref","first-page":"e1656","DOI":"10.1002\/mgg3.1656","article-title":"Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype","volume":"9","author":"Terlizzi","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0022","first-page":"12","article-title":"Effectiveness of elexacaftor\/tezacaftor\/ivacaftor therapy in three subjects with the cystic fibrosis genotype Phe508del\/unknown and advanced lung disease","author":"Terlizzi","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jcf.2022.11.007_bib0023","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbadis.2019.01.029","article-title":"Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del\/F508del Cystic Fibrosis patients","volume":"1865","author":"Kmit","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jcf.2022.11.007_bib0024","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1038\/s41598-017-07504-1","article-title":"Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators","volume":"7","author":"Pranke","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2022.11.007_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jcf.2020.07.015","article-title":"Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants","volume":"20","author":"Laselva","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1113\/JP282586","article-title":"Nasal epithelial cells as a gold-standard predictive model for personalized medicine in cystic fibrosis","author":"Pedemonte","year":"2022","journal-title":"J Physiol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0027","first-page":"58","article-title":"Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells","author":"Sette","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.007_bib0028","first-page":"10","article-title":"Elexacaftor-tezacaftor-ivacaftor therapy for cystic fibrosis patients with the F508del\/unknown genotype","author":"Comegna","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jcf.2022.11.007_bib0029","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95734","article-title":"Nasospheroids permit measurements of CFTR-dependent fluid transport","volume":"2","author":"Guimbellot","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcf.2022.11.007_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcf.2017.06.010","article-title":"Detection of CFTR function and modulation in primary human nasal cell spheroids","volume":"17","author":"Brewington","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0031","first-page":"e14404","article-title":"Changing racial and ethnic differences for lung transplantation in cystic fibrosis","author":"Hayes","year":"2022","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcf.2022.11.007_bib0032","doi-asserted-by":"crossref","first-page":"L550","DOI":"10.1152\/ajplung.00186.2016","article-title":"Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770","volume":"311","author":"Gentzsch","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0033","first-page":"1","article-title":"Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases","author":"Sabusap","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcf.2022.11.007_bib0034","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0035","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcf.2022.11.007_bib0036","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-61779-120-8_18","article-title":"Primary epithelial cell models for cystic fibrosis research","volume":"742","author":"Randell","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0037","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1165\/rcmb.2016-0276MA","article-title":"Pharmacological rescue of conditionally reprogrammed cystic fibrosis bronchial epithelial cells","volume":"56","author":"Gentzsch","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0038","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jcf.2020.05.007","article-title":"In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells","volume":"19","author":"Rayner","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0039","first-page":"59","article-title":"Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration","author":"Morrison","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.007_bib0040","first-page":"38","article-title":"Long-term expanding human airway organoids for disease modeling","author":"Sachs","year":"2019","journal-title":"EMBO J"},{"key":"10.1016\/j.jcf.2022.11.007_bib0041","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jcf.2017.09.005","article-title":"Recent progress in translational cystic fibrosis research using precision medicine strategies","volume":"17","author":"Cholon","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102210","article-title":"Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics","volume":"64","author":"Cholon","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0043","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ebiom.2014.12.005","article-title":"Measurements of functional responses in human primary lung cells as a basis for personalized therapy for cystic fibrosis","volume":"2","author":"Awatade","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jcf.2022.11.007_bib0044","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00536.2020","article-title":"A simple method to generate human airway epithelial organoids with externally-oriented apical membranes","author":"Boecking","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0045","article-title":"Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: cystic fibrosis airway chip","author":"Plebani","year":"2021","journal-title":"J Cyst Fibros."},{"key":"10.1016\/j.jcf.2022.11.007_bib0046","doi-asserted-by":"crossref","first-page":"L526","DOI":"10.1152\/ajplung.00153.2021","article-title":"Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures","volume":"322","author":"van Riet","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.06.004","article-title":"Recent advances in lung-on-a-chip models","author":"Francis","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jcf.2022.11.007_bib0048","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1021\/acsbiomaterials.1c01463","article-title":"3D Lung-on-chip model based on biomimetically microcurved culture membranes","volume":"8","author":"Baptista","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.jcf.2022.11.007_bib0049","first-page":"17","article-title":"Lung-On-A-chip technologies for disease modeling and drug development","volume":"7","author":"Konar","year":"2016","journal-title":"Biomed Eng Comput Biol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0050","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jcf.2022.11.007_bib0051","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jcf.2019.11.002","article-title":"Intestinal organoids for cystic fibrosis research","volume":"19","author":"de Poel","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0052","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0053","first-page":"57","article-title":"Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis","author":"Ramalho","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.007_bib0054","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","article-title":"Rectal organoids enable personalized treatment of cystic fibrosis","volume":"26","author":"Berkers","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcf.2022.11.007_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100019","article-title":"Protocol for application, standardization and validation of the forskolin-induced swelling assay in cystic fibrosis human colon organoids","volume":"1","author":"Vonk","year":"2020","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jcf.2022.11.007_bib0056","unstructured":"Commission, E. Personalised treatment for cystic fibrosis patients with ultra-rare CFTR mutations, https:\/\/cordis.europa.eu\/project\/id\/755021\/reporting. HIT-CF 2022."},{"key":"10.1016\/j.jcf.2022.11.007_bib0057","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/thoraxjnl-2020-216368","article-title":"Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis","volume":"76","author":"Cuyx","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2022.11.007_bib0058","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2018.02.007","article-title":"Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity","volume":"17","author":"Zomer-van Ommen","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.11.007_bib0059","first-page":"12","article-title":"Theratyping of the rare CFTR variants E193K and R334W in rectal organoid-derived epithelial monolayers","author":"Ciciriello","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jcf.2022.11.007_bib0060","doi-asserted-by":"crossref","first-page":"C866","DOI":"10.1152\/ajpcell.00404.2009","article-title":"Influence of cell background on pharmacological rescue of mutant CFTR","volume":"298","author":"Pedemonte","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0061","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pupt.2010.02.001","article-title":"DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers","volume":"23","author":"Rowe","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jcf.2022.11.007_bib0062","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.0706974104","article-title":"Processing and function of CFTR-DeltaF508 are species-dependent","volume":"104","author":"Ostedgaard","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcf.2022.11.007_bib0063","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1113\/jphysiol.2005.096669","article-title":"Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers","volume":"569","author":"Bebok","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.jcf.2022.11.007_bib0064","first-page":"23","article-title":"The L467F-F508del complex allele hampers pharmacological rescue of mutant CFTR by elexacaftor\/tezacaftor\/ivacaftor in cystic fibrosis patients: the value of the ex vivo nasal epithelial model to address non-responders to CFTR-modulating drugs","author":"Sondo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcf.2022.11.007_bib0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/cts.12927","article-title":"G970R-CFTR mutation (c.2908G>C) results predominantly in a splicing defect","volume":"14","author":"Fidler","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jcf.2022.11.007_bib0066","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01994-2021","article-title":"Medicine, N.T.i.P. CFTR variants are associated with chronic bronchitis in smokers","author":"Saferali","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2022.11.007_bib0067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251881","article-title":"Association of the CFTR gene with asthma and airway mucus hypersecretion","volume":"16","author":"Crespo-Lessmann","year":"2021","journal-title":"PLoS One"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:12:54Z","timestamp":1778821974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322014199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":67,"alternative-id":["S1569199322014199"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.11.007","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived cell models for personalized medicine approaches in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}